Chronic renal failure is associated with a 20-fold increased risk of cardiovascular mortality, in part due to accelerated atherosclerosis. Hyperhomocysteinemia (HHCy) is common in patients with chronic renal failure. It has been established that HHCy is an independent and graded risk factor for atherosclerosis, though the mechanisms responsible for it remain obscure. Using the cardiovascular cDNA microarray approach, we screened the expression of 600 cardiovascular relevant genes in human umbilical endothelial cells and identified a number of homocysteine-modulated genes. These differentially displayed genes were classified according to the functional outcome of their encoded proteins: endothelial motility cluster, signaling cluster, and lipid metabolism cluster. The results may be relevant to understanding the mechanisms underlying the pathophysiological effects of HHCy, particularly those leading to endothelial dysfunction and the pathogenesis of atherosclerosis.

Keywords:
Homocysteine, Gene microarray, Atherosclerosis
1.
Boushey C, Beresford S, Omenn G, Motulsky A: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intake. JAMA 1995;274:1049–1057.
2.
Graham IM, Daly L, Refsum H, Robinson K, Brattstrom L, Ueland PM: Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. JAMA 1997;277:1775–1781.
3.
Refsum H, Ueland P, Nygard O, Vollset S: Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31–62.
4.
Manns BJ, Burgess ED, Hyndmann ME, Parsons HG, Schaefer JP, Scott-Douglas NW: Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Am J Kidney Dis 1999;34:669–677.
5.
Robinson K, Gupta A, Dennis V, Arheart K, Chaudhary D, Green R, Vigo P, Mayer E, Selhub J, Kutner M, Jacobsen D: Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996;94:2743–2748.
6.
Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801–809.
7.
Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky MS: Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 2000;279:F671–F678.
8.
Young R: Biomedical discovery with DNA arrays. Cell 2000;102:9–15.
9.
Dangond F: Chips around the world: Physiol Genomics 2000;2:53–58.
10.
Hiltunen M, Niemi M, Yla-Herttuala S: Functional genomics and DNA array techniques in atherosclerosis research. Curr Opin Lipidol 1999;10:515–519.
11.
de Waard V, van den Berg B, Veken J, Schultz-Heienbrock R, Pannekoek H, van Zonneveld AJ: Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus. Gene 1999;226:1–8.
12.
Shiffman D, Mikita T, Tai J, Wade D, Porter G, Seilhamer J, Somogyi R, Liang S, Lawn R: Large-scale gene expression analysis of cholesterol-loaded macrophages. J Biol Chem 2000;275:37324–37332.
13.
Kahn J, Mehraban F, Ingle G, Xin X, Bryant J, Vehar G, Schoenfeld J, Grimaldi C, Peale F, Draksharapu A, Lewin D, Gerritsen M: Gene expression profiling in an in vitro model of angiogenesis. Am J Pathol 2000;156:1887–1900.
14.
Li H, Brodsky S, Kumari S, Valiunas V, Brink P, Kaide J, Nasjletti A, Goligorsky MS: Paradoxical overexpression and translocation of connexin-43 in homocysteine-treated endothelial cells. Am J Physiol, Heart 2002, in press.
15.
Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, Lentz SR: Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res 2001;88:1203–1209.
16.
Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T: Redox-sensitive regulation of lox-1 gene expression in vascular endothelium. Biochem Biophys Res Commun 2001;281:720–725.
17.
Nightingale AK, James PP, Morris-Thurgood J, Harrold F, Tong R, Jackson SK, Cockcroft JR, Frenneaux MP: Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model. Am J Physiol Heart Circ Physiol 2001;280:H1334–H1339.
18.
Schlaich MP, John S, Jacobi J, Lackner KJ, Schmieder RE: Mildly elevated homocysteine concentrations impair endothelium dependent vasodilation in hypercholesterolemic patients. Atherosclerosis 2000;153:383–389.
19.
Zhang S, Day IN, Ye S: Microarray analysis of nicotine-induced changes in gene expression in endothelial cells. Physiol Genomics 2001;5:187–192.
20.
d’Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, Katusic ZS: Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2001;21:1017–1022.
21.
Zhao SP, Xu DY: Oxidized lipoprotein(a) enhanced the expression of P-selectin in cultured human umbilical vein endothelial cells. Thromb Res 2000;100:501–510.
22.
Bishop GG, McPherson JA, Sanders JM, Hesselbacher SE, Feldman MJ, McNamara CA, Gimple LW, Powers ER, Mousa SA, Sarembock IJ: Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 2001;103:1906–1911.
23.
Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999;398:718–723.
24.
Jerome WG, Cash C, Webber R, Horton R, Yancey PG: Lysosomal lipid accumulation from oxidized low density lipoprotein is correlated with hypertrophy of the Golgi apparatus and trans-Golgi network. J Lipid Res 1998;39:1362–1371.
25.
Marcus AJ, Hajjar DP: Vascular transcellular signaling. J Lipid Res 1993;34:2017–2031.
26.
Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke J: Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833–839.
27.
Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999;99:1726–1732.
28.
Murakami K, Ma W, Fuleihan R, Pober JS: Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA. J Immunol 1999;163:2667–2673.
29.
Poddar R, Sivasubramanian N, DiBello P, Robinson K, Jacobsen D: Homocysteine induces expression and secretion of monocyte chomoattractant protein-1 and interleukin-8 in human aortic endothelial cells: Implications for vascular disease. Circulation 2001;103:2717–2723.
30.
Elices MJ: Leukocyte integrins; in Cheresh D, Mecham R (eds): Integrins. San Diego, Academic Press, 1994, pp 163–194.
31.
Li H, Brodsky S, Rieger R, Iden C, Goligorsky MS: Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme A reductase in vascular endothelial cells: A mechanism for development of atherosclerosis? Circulation 2002, in press.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.